103 related articles for article (PubMed ID: 3732352)
41. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk.
Kampert JB; Whittemore AS; Paffenbarger RS
Am J Epidemiol; 1988 Nov; 128(5):962-79. PubMed ID: 3189296
[TBL] [Abstract][Full Text] [Related]
42. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.
Wallgren A; Bonetti M; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Holmberg SB; Lindtner J; Thürlimann B; Fey M; Werner ID; Forbes JF; Price K; Coates AS; Collins J;
J Clin Oncol; 2003 Apr; 21(7):1205-13. PubMed ID: 12663706
[TBL] [Abstract][Full Text] [Related]
43. Correlation between changes in prolactin and melatonin serum levels after radical mastectomy.
Lissoni P; Paolorossi F; Barni S; Tancini G; Crispino S; Rovelli F; Ferri L; Esposti G; Esposti D; Fraschini F
Tumori; 1987 Jun; 73(3):263-7. PubMed ID: 3603722
[TBL] [Abstract][Full Text] [Related]
44. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
45. An abnormal early evening peak of plasma prolactin in nulliparous and obese post-menopausal women.
Kwa HG; Bulbrook RD; Cleton F; Verstraeten AA; Hayward JL; Wang DY
Int J Cancer; 1978 Dec; 22(6):691-3. PubMed ID: 721324
[TBL] [Abstract][Full Text] [Related]
46. [Prolactin and human cancer of the breast. I. Levels of correlation].
Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V
Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536
[TBL] [Abstract][Full Text] [Related]
47. Steroid receptors and prognosis in operable (stage I and II) breast cancer.
Stewart JF; Rubens RD; Millis RR; King RJ; Hayward JL
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1381-7. PubMed ID: 6315442
[TBL] [Abstract][Full Text] [Related]
48. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
Robyn C; Vekemans M
Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
[TBL] [Abstract][Full Text] [Related]
49. Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients.
Poikonen P; Saarto T; Elomaa I; Joensuu H; Blomqvist C
Eur J Cancer; 2000 Jan; 36(1):43-8. PubMed ID: 10741293
[TBL] [Abstract][Full Text] [Related]
50. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment.
de Waard F; Kwa HG; Poortman J
Oncology; 1980; 37(1):33-6. PubMed ID: 7350553
[TBL] [Abstract][Full Text] [Related]
51. [Correlations between PRL and 17-beta-E in human breast cancer].
Larrad Jiménez A; Ruiz-Tartas A; Zapatero Gaviria J; López Lazareno N
Rev Esp Oncol; 1984; 31(2):279-87. PubMed ID: 6549590
[TBL] [Abstract][Full Text] [Related]
52. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
[TBL] [Abstract][Full Text] [Related]
53. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity.
Lara-Medina F; Pérez-Sánchez V; Saavedra-Pérez D; Blake-Cerda M; Arce C; Motola-Kuba D; Villarreal-Garza C; González-Angulo AM; Bargalló E; Aguilar JL; Mohar A; Arrieta Ó
Cancer; 2011 Aug; 117(16):3658-69. PubMed ID: 21387260
[TBL] [Abstract][Full Text] [Related]
54. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women.
Bernstein L; Pike MC; Ross RK; Judd HL; Brown JB; Henderson BE
J Natl Cancer Inst; 1985 Apr; 74(4):741-5. PubMed ID: 3857369
[TBL] [Abstract][Full Text] [Related]
55. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
56. Epidemiology of breast cancer.
Marchant DJ
Clin Obstet Gynecol; 1982 Jun; 25(2):387-92. PubMed ID: 7105514
[TBL] [Abstract][Full Text] [Related]
57. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
[TBL] [Abstract][Full Text] [Related]
58. Relationship of oestrogen-receptor status to survival in breast cancer.
Bishop HM; Blamey RW; Elston CW; Haybittle JL; Nicholson RI; Griffiths K
Lancet; 1979 Aug; 2(8137):283-4. PubMed ID: 88612
[TBL] [Abstract][Full Text] [Related]
59. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer.
Badwe RA; Gregory WM; Chaudary MA; Richards MA; Bentley AE; Rubens RD; Fentiman IS
Lancet; 1991 May; 337(8752):1261-4. PubMed ID: 1674070
[TBL] [Abstract][Full Text] [Related]
60. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.
Hankinson SE; Willett WC; Michaud DS; Manson JE; Colditz GA; Longcope C; Rosner B; Speizer FE
J Natl Cancer Inst; 1999 Apr; 91(7):629-34. PubMed ID: 10203283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
